The Body of Evidence – What We Know, and What We’re Learning

147 views
November 16, 2022

This session from HFSA 2022 will explain what Cardiac Contractility Modulation therapy is, how it works, and the expected outcomes when utilizing this treatment for HF in NYHA Class III patients who remain symptomatic despite guideline directed medical therapy.

Dr. Javed Butler breaks down the mechanism of action of CCM® therapy and provides an overview of both historical and ongoing clinical trials, as well as planned future studies.

Comments 0
Login to view comments. Click here to Login